Drug Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
BLTE | A | Belite Bio, Inc. | 0.00 | |
RIGL | B | Rigel Pharmaceuticals, Inc. | 0.00 | |
ALGS | B | Aligos Therapeutics, Inc. | 0.00 | |
MNMD | B | Mind Medicine (MindMed) Inc. | 0.00 | |
ITCI | B | Intra-Cellular Therapies Inc. | 0.00 | |
CDXS | C | Codexis, Inc. | 0.00 | |
ENZ | C | Enzo Biochem, Inc. | 0.00 | |
SWTX | C | SpringWorks Therapeutics, Inc. | 0.00 | |
LDOS | C | Leidos Holdings, Inc. | 0.00 | |
NOTV | C | Inotiv, Inc. | 0.00 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Semiconductor Equipment & Materials
Related Stock Lists:
Cancer
Alcohol
Autoimmune Disease
Biopharmaceutical
Biotechnology
Clinical Medicine
Diabetes
Enzymes
Hepatitis
Life Sciences
Liver Disease
Medicine
Non Alcoholic Fatty Liver Disease
Ophthalmic
Pharmaceutical
Pharmacy
Steatohepatitis
Acid
Active Pharmaceutical Ingredients
Adenosine
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PSIL | C | AdvisorShares Psychedelics ETF | 15.41 | |
XPH | C | SPDR S&P Pharmaceuticals ETF | 5.1 | |
SHLD | B | Global X Defense Tech ETF | 4.86 | |
HACK | B | ETFMG Prime Cyber Security ETF | 4.51 | |
CIBR | B | First Trust NASDAQ CEA Cybersecurity ETF | 4.5 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Semiconductor Equipment & Materials
Related Stock Lists:
Cancer
Alcohol
Autoimmune Disease
Biopharmaceutical
Biotechnology
Clinical Medicine
Diabetes
Enzymes
Hepatitis
Life Sciences
Liver Disease
Medicine
Non Alcoholic Fatty Liver Disease
Ophthalmic
Pharmaceutical
Pharmacy
Steatohepatitis
Acid
Active Pharmaceutical Ingredients
Adenosine
- Drug Development
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles